Minerva Neurosciences Inc (NASDAQ:NERV)

6.17
BATS BZX Real-Time Price
As of 9:48am ET
 +0.13 / +2.15%
Today’s Change
1.26
Today|||52-Week Range
15.27
+288.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$30.6M

Company Description

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson's disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Contact Information

Minerva Neurosciences, Inc.
1500 District Avenue
Burlington Massachusetts 01803
P:(617) 600-7373
Investor Relations:

Employees

Shareholders

Other institutional4.58%
Mutual fund holders27.68%
Individual stakeholders16.08%

Top Executives

Rémy Henri LuthringerExecutive Chairman & Chief Executive Officer
Geoff RacePresident
Joseph ReillyChief Operating Officer & Senior Vice President
Fred AhlholmChief Financial Officer, Secretary & Senior VP
Michael DavidsonChief Medical Officer